RAVISRO Study - Postoperative Outcomes of Radical Visceral resections in Oncosurgery
Not Applicable
Recruiting
- Conditions
- Health Condition 1: C260- Malignant neoplasm of intestinal tract, part unspecified
- Registration Number
- CTRI/2024/08/072057
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients aged 18 years and above who are undergoing elective onco-surgical procedures that involve radical visceral resections and are shifted postoperatively to the surgical ICU.
1) Cytoreductive surgery (CRS) plus Hyperthermic Intraperitoneal Chemotherapy
(HIPEC)
2) Transthoracic esophagectomy (TTE) plus 3-field lymph node dissection
3) Hepatectomy
4) Parenchyma-sparing liver metastatectomy
5) Radical cholecystectomy
6) Extrahepatic biliary tree excision
7) Whipple’s procedure with or without vascular reconstruction
8) Retroperitoneal sarcoma excision
9) Pelvic exenteration surgery
Exclusion Criteria
Redo surgeries that involve radical visceral resections within 30 days of primary surgery will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of Clavien-Dindo postoperative complications and the Comprehensive Complication Index (CCI)Timepoint: at discharge and at 30 days
- Secondary Outcome Measures
Name Time Method Morbidity predictorsTimepoint: 90 days